AU7648374A - Vincamine derivatives - Google Patents

Vincamine derivatives

Info

Publication number
AU7648374A
AU7648374A AU76483/74A AU7648374A AU7648374A AU 7648374 A AU7648374 A AU 7648374A AU 76483/74 A AU76483/74 A AU 76483/74A AU 7648374 A AU7648374 A AU 7648374A AU 7648374 A AU7648374 A AU 7648374A
Authority
AU
Australia
Prior art keywords
vincamine derivatives
vincamine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU76483/74A
Other versions
AU492672B2 (en
Inventor
Pfann Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1768973A external-priority patent/CH588488A5/en
Priority claimed from CH162174A external-priority patent/CH596207A5/en
Priority claimed from CH176574A external-priority patent/CH593283A5/en
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of AU492672B2 publication Critical patent/AU492672B2/en
Publication of AU7648374A publication Critical patent/AU7648374A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D461/00Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU76483/74A 1973-12-18 1974-12-16 Vincamine derivatives Expired AU492672B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1768973A CH588488A5 (en) 1973-12-18 1973-12-18 Vincamine derivs for treating behaviour disorders - by ring closure of indoloquinolizine deriv
CHCH17689/73 1973-12-18
CH162174A CH596207A5 (en) 1974-02-06 1974-02-06 Vincamine derivs for treating behaviour disorders
CH176574A CH593283A5 (en) 1974-02-08 1974-02-08 Vincamine derivs for treating behaviour disorders - by ring closure of indoloquinolizine deriv

Publications (2)

Publication Number Publication Date
AU492672B2 AU492672B2 (en) 1976-06-17
AU7648374A true AU7648374A (en) 1976-06-17

Family

ID=

Also Published As

Publication number Publication date
MY8100186A (en) 1981-12-31
FR2254342B1 (en) 1978-07-21
DE2458164C2 (en) 1991-04-18
HK53980A (en) 1980-10-03
SE422798B (en) 1982-03-29
JPS50105700A (en) 1975-08-20
CA1051899A (en) 1979-04-03
DK139358C (en) 1979-07-09
SE7415416L (en) 1975-06-19
DD116043A5 (en) 1975-11-05
ES432952A1 (en) 1977-02-16
DK139358B (en) 1979-02-05
FI59096B (en) 1981-02-27
GB1492579A (en) 1977-11-23
JPS5817474B2 (en) 1983-04-07
DE2458164A1 (en) 1975-06-26
IE40791B1 (en) 1979-08-15
DK639774A (en) 1975-08-25
FR2254342A1 (en) 1975-07-11
PH12927A (en) 1979-10-10
ES450741A1 (en) 1978-03-16
ES450740A1 (en) 1977-12-16
IE40791L (en) 1975-06-18
FI59096C (en) 1981-06-10
NL7416237A (en) 1975-06-20
NO744456L (en) 1975-07-14
FI355274A (en) 1975-06-19

Similar Documents

Publication Publication Date Title
AU468242B2 (en) 2-cyclohexene-1-one derivatives
CA1032944A (en) Indole derivatives
CA1020171A (en) 2-methylbenzamide derivatives
CA1025856A (en) Quinoline-3-carboxamidotetrazole derivatives
CA1029036A (en) Octahydro-acetonaphthone derivatives
HK53980A (en) Vincamine derivatives
CA1018170A (en) Lactamimide derivatives
CA1019749A (en) Beneoxazolinone derivatives
CA1018160A (en) Theophylline derivatives
AU476540B2 (en) 7-(cyanomethylaryl) acetamide-cephalosporin derivatives
CA1022549A (en) Ergoline derivatives
AU492672B2 (en) Vincamine derivatives
AU458655B2 (en) Benzenesulfonylurea derivatives
CA1024154A (en) Nor-sesquiterpene derivatives
AU485468B2 (en) Ergoline derivatives
CA1002947A (en) Imidazo-benzodiazepine derivatives
AU487016B2 (en) Debenzocycoheptene derivatives
AU483899B2 (en) 7- methoxycephalosporin derivatives
AU479245B2 (en) 8-azapurin-6-one derivatives
AU479187B2 (en) Triazolobenzoidiazepine derivatives
AU470521B2 (en) 5-benzyl-pyrimidine derivatives
AU480266B2 (en) 4-o-sulfonyl erythromycin-9-o-oxime derivatives
CA1007249A (en) 4-alkoxy-4-phenylcyclohexylamine derivatives
AU495842B2 (en) Ryrimidine derivatives
AU482770B2 (en) 4-deoxy-4-oxoerythromycin b derivatives